Prospective Natural History Study of Retinitis Pigmentosa (NCT04285398)

🧪 Interventions in This Study

• Ophthalmic examinations (OTHER)
• Mobility Test (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• UPMC Eye Center — Pittsburgh, Pennsylvania
• CHNO XV-XX Paris - CIC 1423 — Paris,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Retinitis Pigmentosa

• Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) — Phoenix, Arizona
• Natural History of PRPF31 Mutation-Associated Retinal Dystrophy — San Francisco, California
• Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) — Beverly Hills, California
• FIGHT-RP 1 Extension Study — Baltimore, Maryland
• Promising ROd-cone DYstrophy Gene therapY — Miami, Florida

Explore by condition: All Retinitis Pigmentosa clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.